ASPP1/2 regulate p53-dependent death of retinal ganglion cells through PUMA and Fas/CD95 activation In Vivo

Journal of Neuroscience

Volumn 33, Issue 5, 2013, Pages 2205-2216

  Wilson, Ariel M ^a   Morquette, Barbara ^a   Abdouh, Mohamed ^b   Unsain, Nicolás ^c   Barker, Philip A ^c   Feinstein, Elena ^d   Bernier, Gilbert ^b   Di Polo, Adriana ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d QBI Enterprises Ltd   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; APOPTOSIS STIMULATING OF 53 PROTEIN 1; APOPTOSIS STIMULATING OF 53 PROTEIN 2; PROTEIN BAX; PROTEIN NOXA; PROTEIN P53; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE SILENCING; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE FIBER TRANSECTION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE LESION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RETINA GANGLION CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD95; APOPTOSIS REGULATORY PROTEINS; AXONS; CELL DEATH; DOWN-REGULATION; FEMALE; MICE; MICE, KNOCKOUT; RATS; RATS, SPRAGUE-DAWLEY; RETINAL GANGLION CELLS; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84873020899     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2635-12.2013     Document Type: Article

References (66)

1. Agirre X, Román-Gómez J, Jiménez-Velasco A, Garate L, Montiel-Duarte C, Navarro G, Vázquez I, Zalacain M, Calasanz MJ, Heiniger A, Torres A, Minna JD, Prósper F (2006) ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia. Oncogene 25:1862-1870. CrossRef Medline
2. Ahmed Z, Kalinski H, Berry M, Almasieh M, Ashush H, Slager N, Brafman A, Spivak I, Neeha Prasad N, Mett I, Shalom E, Alpert E, Di Polo A, Feinstein E, Logan A (2011) Ocular neuroprotection by siRNA targeting caspase-2. Cell Death Dis 2:e173. CrossRef Medline
3. Aikawa T, Shinzawa K, Tanaka N, Tsujimoto Y (2010) Noxa is necessary for hydrogen peroxide-induced caspase-dependent cell death. FEBS Letts 584:681-688. CrossRef Medline
4. Amano T, Nakamizo A, Mishra SK, Gumin J, Shinojima N, Sawaya R, Lang FF (2009) Simultaneous phosphorylation of p53 at serine 15 and 20 induces apoptotic genes. J Neurooncol 92:357-371. CrossRef Medline
5. Ao Y, Rohde LH, Naumovski L (2001) p53-interacting protein 53BP2 in-hibits clonogenic survival and sensitizes cells to doxorubicin but not paclitaxel-induced apoptosis. Oncogene 20:2720-2725. CrossRef Medline
6. Armstrong JL, Flockhart R, Veal GJ, Lovat PE, Redfern CP (2010) Regula-tion of endoplasmic reticulum stress-induced cell death by ATF4 in neu-roectodermal tumor cells. J Biol Chem 285:6091-6100. CrossRef Medline
7. Ashkenazi A (2002) Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2:420-430. CrossRef Medline
8. Aylon Y, Ofir-Rosenfeld Y, Yabuta N, Lapi E, Nojima H, Lu X, Oren M (2010) The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1. Gene Dev 24:2420-2429. CrossRef Medline
9. Bergamaschi D, Samuels Y, O'Neil NJ, Trigiante G, Crook T, Hsieh JK, O'Connor DJ, Zhong S, Campargue I, Tomlinson ML, Kuwabara PE, Lu X (2003) iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet 33:162-167. CrossRef Medline
10. Bergamaschi D, Samuels Y, Sullivan A, Zvelebil M, Breyssens H, Bisso A, Del Sal G, Syed N, Smith P, Gasco M, Crook T, Lu X (2006) iASPP preferentially binds p53 prolinerich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet 38:1133-1141. CrossRef Medline
11. Berkelaar M, Clarke DB, Wang YC, Bray GM, Aguayo AJ (1994) Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci 14:4368-4374. Medline
12. Boehme KA, Blattner C (2009) Regulation of p53-insights into a complex process. Crit Rev Biochem Mol Biol 44:367-392. CrossRef Medline
13. Budhram-Mahadeo VS, Bowen S, Lee S, Perez-Sanchez C, Ensor E, Morris PJ, Latchman DS (2006) Brn-3b enhances the pro-apoptotic effects of p53 but not its induction of cell cycle arrest by cooperating in trans-activation of bax expression. Nucl Acids Res 34:6640-6652. CrossRef Medline
14. Chang JR, Ghafouri M, Mukerjee R, Bagashev A, Chabrashvili T, Sawaya BE (2012) Role of p53 in neurodegenerative diseases. Neurodegener Dis 9:68-80. CrossRef Medline
15. Chatoo W, Abdouh M, David J, Champagne MP, Ferreira J, Rodier F, Bernier G (2009) The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity. J Neurosci 29: 529-542. CrossRef Medline
16. Chatoo W, Abdouh M, Bernier G (2011) p53 pro-oxidant activity in the central nervous system: implication in aging and neurodegenerative diseases. Antioxid Redox Signal 15:1729-1737. CrossRef Medline
17. Cheng L, Sapieha P, Kittlerová P, Hauswirth WW, Di Polo A (2002) TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J Neurosci 22:3977-3986. Medline
18. Chipuk JE, Green DR (2009) PUMA cooperates with direct activator proteins to promote mitochondrial outer membrane permeabilization and apoptosis. Cell Cycle 8:2692-2696. CrossRef Medline
19. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR (2005) PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309:1732-1735. CrossRef Medline
20. Culmsee C, Mattson MP (2005) p53 in neuronal apoptosis. Biochem Biophys Res Comm 331:761-777. CrossRef Medline
21. Czauderna F, Fechtner M, Dames S, Aygun H, Klippel A, Pronk GJ, Giese K, Kaufmann J (2003) Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res 31:2705-2716. CrossRef Medline
22. Dhar SK, Xu Y, Chen Y, St Clair DK (2006) Specificity protein 1-dependent p53-mediated suppression of human manganese superoxide dismutase gene expression. J Biol Chem 281:21698-21709. CrossRef Medline
23. Di Giovanni S, Rathore K (2012) p53-dependent pathways in neurite outgrowth and axonal regeneration. Cell Tissue Res 349:87-95. CrossRef Medline
24. Di Giovanni S, Knights CD, Rao M, Yakovlev A, Beers J, Catania J, Avantag-giati ML, Faden AI (2006) The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration. EMBO J 25:4084-4096. CrossRef Medline
25. Dumaz N, Meek DW (1999) Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J 18:7002-7010. CrossRef Medline
26. Gaub P, Tedeschi A, Puttagunta R, Nguyen T, Schmandke A, Di Giovanni S (2010) HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation. Cell Death Differ 17:1392-1408. CrossRef Medline
27. Gaub P, Joshi Y, Wuttke A, Naumann U, Schnichels S, Heiduschka P, Di Giovanni S (2011) The histone acetyltransferase p300 promotes intrinsic axonal regeneration. Brain 134:2134-2148. CrossRef Medline
28. Gorina S, Pavletich NP (1996) Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274:1001-1005. CrossRef Medline
29. Gregory MS, Hackett CG, Abernathy EF, Lee KS, Saff RR, Hohlbaum AM, Moody KS, Hobson MW, Jones A, Kolovou P, Karray S, Giani A, John SW, Chen DF, Marshak-Rothstein A, Ksander BR (2011) Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death. PLoS One 6:e17659. CrossRef Medline
30. Haase G, Pettmann B, Raoul C, Henderson CE (2008) Signaling by death receptors in the nervous system. Curr Opin Neurobiol 18:284-291. CrossRef Medline
31. Hamar P, Song E, Kökény G, Chen A, Ouyang N, Lieberman J (2004) Small interfering RNA targeting Fas protects mice against renal ischemiareperfusion injury. Proc Natl Acad Sci U S A 101:14883-14888. CrossRef Medline
32. Iwabuchi K, Bartel PL, Li B, Marraccino R, Fields S (1994) Two cellular proteins that bind to wild-type but not mutant p53. Proc Natl Acad Sci USA 91:6098-6102.CrossRefMedline
33. Ju KR, Kim HS, Kim JH, Lee NY, Park CK (2006) Retinal glial cell responses and Fas/FasL activation in rats with chronic ocular hypertension. Brain Res 1122:209-221. CrossRef Medline
34. Koeberle PD, Wang Y, Schlichter LC (2010) Kv1.1 and Kv1.3 channels contribute to the degeneration of retinal ganglion cells after optic nerve transection in vivo. Cell Death Differ 17:134-144. CrossRef Medline
35. Lebrun-Julien F, Morquette B, Douillette A, Saragovi HU, Di Polo A (2009) Inhibition of p75NTR in glia potentiates TrkA-mediated survival of injured retinal ganglion ells. Mol Cell Neurosci 40:410-420. CrossRef Medline
36. Leon S, Yin Y, Nguyen J, Irwin N, Benowitz LI (2000) Lens injury stimulates axon regeneration in the mature rat optic nerve. J Neurosci 20:4615-4626. Medline
37. Li Y, Schlamp CL, Poulsen GL, Jackson MW, Griep AE, Nickells RW (2002) p53 regulates apoptotic retinal ganglion cell death induced by N-methyl-D-aspartate. Mol Vis 8:341-350. Medline
38. Lingor P, Koeberle P, Kugler S, Bähr M (2005) Down-regulation of apoptosis mediators by RNAi inhibits axotomy-induced retinal ganglion cell death in vivo. Brain 128:550-558. CrossRef Medline
39. Liu ZJ, Zhang Y, Zhang XB, Yang X (2004) Abnormal mRNA expression of ASPP members in leukemia cell lines. Leukemia 18:880. CrossRef Medline
40. Liu ZJ, Lu X, Zhang Y, Zhong S, Gu SZ, Zhang XB, Yang X, Xin HM (2005) Downregulated mRNA expression of ASPP and the hypermethylation of the 5-untranslated region in cancer cell lines retaining wild-type p53. FEBS Lett 579:1587-1590. CrossRef Medline
41. Lopez CD, Ao Y, Rohde LH, Perez TD, O'Connor DJ, Lu X, Ford JM, Nau-movski L (2000) Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53. Mol Cell Biol 20:8018-8025. CrossRef Medline
42. Lossos IS, Natkunam Y, Levy R, Lopez CD (2002) Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome. Leuk Lymphoma 43:2309-2317. CrossRef Medline
43. Mansour-Robaey S, Clarke DB, Wang YC, Bray GM, Aguayo AJ (1994) Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci U S A 91:1632-1636. CrossRef Medline
44. Nagase T, Ishikawa K, Suyama M, Kikuno R, Hirosawa M, Miyajima N, Tanaka A, Kotani H, Nomura N, Ohara O (1998) Prediction of the coding sequences of unidentified humangGenes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res 5:355-364. CrossRef Medline
45. Nakano K, Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7:683-694. CrossRef Medline
46. O'Connor JC, Wallace DM, O'Brien CJ, Cotter TG (2008) A novel antioxidant function for the tumor-suppressor gene p53 in the retinal ganglion cell. Invest Ophthalmol Vis Sci 49:4237-4244. CrossRef Medline
47. Park KK, Liu K, Hu Y, Smith PD, Wang C, Cai B, Xu B, Connolly L, Kramvis I, Sahin M, He Z (2008) Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 322:963-966. CrossRef Medline
48. Patel S, George R, Autore F, Fraternali F, Ladbury JE, Nikolova PV (2008) Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax. Nucleic Acids Res 36:5139-5151. CrossRef Medline
49. Pernet V, Di Polo A (2006) Synergistic action of brain-derived neurotrophic factor and lens injury promotes retinal ganglion cell survival, but leads to optic nerve dystrophy in vivo. Brain 129:1014-1026. CrossRef Medline
50. Pernet V, Hauswirth WW, Di Polo A (2005) Extracellular signal-regulated kinase 1/2 mediates survival, but not axon regeneration, of adult injured central nervous system neurons in vivo. J Neurochem 93:72-83. CrossRef Medline
51. Perry VH (1981) Evidence for an amacrine cell system in the ganglion cell layer of the rat retina. Neuroscience 6:931-944. CrossRef Medline
52. Peter ME, Budd RC, Desbarats J, Hedrick SM, Hueber AO, Newell MK, Owen LB, Pope RM, Tschopp J, Wajant H, Wallach D, Wiltrout RH, Zörnig M, Lynch DH (2007) The CD95 receptor: apoptosis revisited. Cell 129:447-450. CrossRef Medline
53. Rosenbaum DM, Rosenbaum PS, Gupta H, Singh M, Aggarwal A, Hall DH, Roth S, Kessler JA (1998) The role of the p53 protein in the selective vulnerability of the inner retina to transient ischemia. Invest Ophthalmol Vis Sci 39:2132-2139. Medline
54. Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S, Campargue I, Naumovski L, Crook T, Lu X (2001) ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 8:781-794. CrossRef Medline
55. Schilling T, Schleithoff ES, Kairat A, Melino G, Stremmel W, Oren M, Kram-mer PH, Muller M (2009) Active transcription of the human FAS/CD95/TNFRSF6 gene involves the p53 family. Biochem Biophys Res Commun 387:399-404. CrossRef Medline
56. Slee EA, O'Connor DJ, Lu X (2004) To die or not to die: how does p53 decide? Oncogene 23:2809-2818. CrossRef Medline
57. Soussi T (2000) The p53 tumor suppressor gene: from molecular biology to clinical investigation. Ann N Y Acad Sci 910:121-137. CrossRef Medline
58. Tedeschi A, Nguyen T, Puttagunta R, Gaub P, Di Giovanni S (2009a) A p53-CBP/p300 transcription module is required for GAP-43 expression, axon outgrowth, and regeneration. Cell Death Differ 16:543-554. CrossRef Medline
59. Tedeschi A, Nguyen T, Steele SU, Feil S, Naumann U, Feil R, Di Giovanni S (2009b) The tumor suppressor p53 transcriptionally regulates cGKI expression during neuronal maturation and is required for cGMP-dependent growth cone collapse. J Neurosci 29:15155-15160. CrossRef Medline
60. Unger T, Sionov RV, Moallem E, Yee CL, Howley PM, Oren M, Haupt Y (1999) Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene 18:3205-3212. CrossRef Medline
61. Villegas-Pérez MP, Vidal-Sanz M, Rasminsky M, Bray GM, Aguayo AJ (1993) Rapid and protracted phases of retinal ganglion cell loss follow axotomy in the optic nerve of adult rats. J Neurobiol 24:23-36. CrossRef Medline
62. Vives V, Su J, Zhong S, Ratnayaka I, Slee E, Goldin R, Lu X (2006) ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth. Genes Dev 20:1262-1267. CrossRef Medline
63. Wade M, Wang YV, Wahl GM (2010) The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol 20:299-309. CrossRef Medline
64. Wax MB, Tezel G, Yang J, Peng G, Patil RV, Agarwal N, Sappington RM, Calkins DJ (2008) Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived Fas-ligand. J Neurosci 28:12085-12096. CrossRef Medline
65. Yang JP, Hori M, Sanda T, Okamoto T (1999) Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor. J Biol Chem 274:15662-15670. CrossRef Medline
66. Zhang J, Yan W, Chen X (2006) p53 is required for nerve growth factormediated differentiation of PC12 cells via regulation of TrkA levels. Cell Death Differ 13:2118-2128. CrossRef Medline